Biomarker composition for diagnosing or prognostic analysis of bladder cancer, kit comprising the same and method for diagnosing bladder cancer using the same

摘要

The present invention relates to a biomarker composition, a kit, and a diagnostic method using the same for diagnosis or prognosis of bladder cancer, and more particularly, a formulation measuring the expression level of a protein of soluble FAS; And it relates to a biomarker composition for diagnosis or prognosis analysis of bladder cancer comprising an agent for measuring the expression level of a protein of apolipoprotein A1 or MMP9 (Matrix metallopeptidase 9) as an active ingredient.